Consignment bioequivalence testing will likely be scrapped in May

Published: 2007-02-12 06:56:00

Updated: 2007-02-12 06:56:00

The planned scrapping of consignment bioequivalence testing to ensure its transparency and facilitate the development of generic drugs will be available in May through a variety of procedures under the newly revised rules concerning the safety and efficacy of drugs, etc., according to Korea Food ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK